|
Virginia Foxx
|
house |
GlaxoSmithKline PLC (GSK) [ST] |
GSK |
STOCK |
Purchase
|
April 8, 2022 |
$$1,001 - $15,000 |
May 4, 2022 |
|
Virginia Foxx
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
Feb. 22, 2022 |
$$1,001 - $15,000 |
March 7, 2022 |
|
John Rutherford
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Sale
|
Feb. 17, 2022 |
$$1,001 - $15,000 |
March 16, 2022 |
|
Virginia Foxx
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
Jan. 14, 2022 |
$$1,001 - $15,000 |
Feb. 4, 2022 |
|
Virginia Foxx
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
Oct. 8, 2021 |
$$1,001 - $15,000 |
Nov. 2, 2021 |
|
Virginia Foxx
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
July 9, 2021 |
$$1,001 - $15,000 |
Aug. 2, 2021 |
|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Sale
|
June 4, 2021 |
$$1,001 - $15,000 |
Aug. 15, 2021 |
|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Sale
|
June 4, 2021 |
$$1,001 - $15,000 |
Aug. 15, 2021 |
|
Virginia Foxx
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
April 9, 2021 |
$$1,001 - $15,000 |
May 5, 2021 |
|
Virginia Foxx
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
Jan. 15, 2021 |
$$1,001 - $15,000 |
Feb. 1, 2021 |
|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
Nov. 5, 2020 |
$$1,001 - $15,000 |
Dec. 28, 2020 |
|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
Nov. 5, 2020 |
$$1,001 - $15,000 |
Dec. 28, 2020 |
|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Sale
|
Oct. 22, 2020 |
$$1,001 - $15,000 |
Dec. 3, 2020 |
|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Sale
|
Oct. 22, 2020 |
$$1,001 - $15,000 |
Dec. 3, 2020 |
|
Virginia Foxx
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
Oct. 9, 2020 |
$$1,001 - $15,000 |
Nov. 6, 2020 |
|
Mark W Menezes
|
executive |
GlaxoSmithKline PLC Sponsored ADR |
GSK |
STOCK |
Purchase
|
Sept. 29, 2020 |
$$1,001 - $15,000 |
Oct. 28, 2020 |
|
Virginia Foxx
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
P
|
July 10, 2020 |
$$1,001 - $15,000 |
Aug. 10, 2020 |
|
Virginia Foxx
|
house |
glaxosmithKline PlC (gsK) |
GSK |
STOCK |
P
|
April 13, 2020 |
$$15,001 - $50,000 |
May 4, 2020 |
|
Greg Gianforte
|
house |
GlaxoSmithKline PlC (GSK) |
GSK |
STOCK |
Purchase
|
March 18, 2020 |
$$50,001 - $100,000 |
April 7, 2020 |
|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
March 2, 2020 |
$$1,001 - $15,000 |
April 20, 2020 |
|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
March 2, 2020 |
$$1,001 - $15,000 |
April 20, 2020 |
|
Virginia Foxx
|
house |
glaxosmithKline PlC (gsK) |
GSK |
STOCK |
P
|
Jan. 10, 2020 |
$$1,001 - $15,000 |
Feb. 3, 2020 |
|
Virginia Foxx
|
house |
glaxosmithKline PlC (gsK) |
GSK |
STOCK |
P
|
Oct. 11, 2019 |
$$1,001 - $15,000 |
Nov. 12, 2019 |
|
Virginia Foxx
|
house |
glaxosmithKline PlC (gsK) |
GSK |
STOCK |
[sT]
|
July 12, 2019 |
$$1,001 - $15,000 |
Aug. 8, 2019 |
|
Nicholas Van Taylor
|
house |
GlaxoSmithKline PLC (GSK) |
GSK |
STOCK |
Sale
|
March 25, 2019 |
$$15,001 - $50,000 |
April 15, 2019 |